BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND ERBB3, c-erbB3, 2065, P21860, p180-ErbB3, c-erbB-3, ErbB-3, MDA-BF-1, HER3, p85-sErbB3, MGC88033, p45-sErbB3, ENSG00000065361, erbB3-S AND Treatment
16 results:

  • 1. Disparities in geospatial patterns of cancer care within urban counties and structural inequities in access to oncology care.
    McGee-Avila JK; Richmond J; Henry KA; Stroup AM; Tsui J
    Health Serv Res; 2023 Aug; 58 Suppl 2(Suppl 2):152-164. PubMed ID: 37208901
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing.
    Machida H; Matsuo K; Tanaka M; Kitatani K; Takase A; Yokoyama K; Kajiwara H; Yasaka M; Ikeda M; Yoshida H; Hirasawa T; Mikami M
    Gynecol Oncol; 2023 Apr; 171():59-66. PubMed ID: 36804622
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression.
    Liu C; Zhang M; Yan X; Ni Y; Gong Y; Wang C; Zhang X; Wan L; Yang H; Ge C; Li Y; Zou W; Huang R; Li X; Sun B; Liu B; Yue J; Yu J
    Sci Adv; 2023 Jan; 9(4):eadd8977. PubMed ID: 36706185
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. In-silico analysis reveals Quinic acid as a multitargeted inhibitor against cervical cancer.
    Ahmad S; Sayeed S; Bano N; Sheikh K; Raza K
    J Biomol Struct Dyn; 2023 Nov; 41(19):9770-9786. PubMed ID: 36379678
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cdc25A inhibits autophagy-mediated ferroptosis by upregulating ErbB2 through PKM2 dephosphorylation in cervical cancer cells.
    Wang C; Zeng J; Li LJ; Xue M; He SL
    Cell Death Dis; 2021 Nov; 12(11):1055. PubMed ID: 34743185
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genomic profiling of advanced cervical cancer to predict response to programmed death-1 inhibitor combination therapy: a secondary analysis of the CLAP trial.
    Huang X; He M; Peng H; Tong C; Liu Z; Zhang X; Shao Y; Zhu D; Zhang J; Yin JC; Yang F; Lan C
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34011535
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
    Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
    Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador.
    Campos NG; Maza M; Alfaro K; Gage JC; Castle PE; Felix JC; Masch R; Cremer M; Kim JJ
    Int J Gynaecol Obstet; 2019 Apr; 145(1):40-46. PubMed ID: 30702142
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [A randomized study of intensity-modulated radiation therapy versus three dimensional conformal radiation therapy for pelvic radiation in patients of post-operative treatment with gynecologic malignant tumor].
    Ni J; Yin ZM; Yuan SH; Liu NF; Li L; Xu XX; Lou HM
    Zhonghua Fu Chan Ke Za Zhi; 2017 Mar; 52(3):168-174. PubMed ID: 28355688
    [No Abstract]    [Full Text] [Related]  

  • 10. Prevalence of Abnormal Papanicolaou Test Results and Related Factors among Women Living in Zanjan, Iran.
    Maleki A; Ahmadnia E; Avazeh A; Mazloomzadeh S; Molaei B; Jalilvand A
    Asian Pac J Cancer Prev; 2015; 16(16):6935-9. PubMed ID: 26514471
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Feasibility, acceptability, and effectiveness of visual inspection of the cervix with acetic acid and cryotherapy for dysplasia in Nigeria.
    Adefuye PO; Dada OA; Adefuye BO; Shorunmu TO; Akinyemi BO; Idowu-Ajiboye BO
    Int J Gynaecol Obstet; 2015 Apr; 129(1):62-6. PubMed ID: 25593107
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Study protocol for the most effective recall method in a cervical cancer screening program in Klang, Malaysia.
    Abdul Rashid RM; Dahlui M
    Asian Pac J Cancer Prev; 2013; 14(10):5867-70. PubMed ID: 24289591
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. CD4 T-LYMPHOCYTE SUBSETS IN WOMEN WITH INVASIVE cervical cancer IN KENYA.
    Gichangi P; Gathece L; Estambale B; Temmerman M
    East Afr Med J; 2013 Oct; 90(10):309-15. PubMed ID: 26862640
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Screening for cervical neoplasia in Bangladesh using visual inspection with acetic acid.
    Nessa A; Hussain MA; Rahman JN; Rashid MH; Muwonge R; Sankaranarayanan R
    Int J Gynaecol Obstet; 2010 Nov; 111(2):115-8. PubMed ID: 20674919
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma.
    Rao PH; Arias-Pulido H; Lu XY; Harris CP; Vargas H; Zhang FF; Narayan G; Schneider A; Terry MB; Murty VV
    BMC Cancer; 2004 Feb; 4():5. PubMed ID: 15018632
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Activation of EGF receptor family members suppresses the cytotoxic effects of tumor necrosis factor-alpha.
    Hoffmann M; Schmidt M; Wels W
    Cancer Immunol Immunother; 1998 Nov; 47(3):167-75. PubMed ID: 9829842
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.